×
About 7,227 results

ALLMedicine™ Endometrial Carcinoma Center

Research & Reviews  3,551 results

Combined use of ICG and technetium does not improve sentinel lymph node detection in en...
https://doi.org/10.1016/j.ygyno.2021.05.002
Gynecologic Oncology; Cabrera S, Barahona-Orpinell M et. al.

May 16th, 2021 - There is scarce evidence available about the benefit of combining technetium (99mTc) and indocyanine green (ICG) for sentinel lymph node (SLN) biopsy in endometrial cancer. The aim of this study was to compare the overall and bilateral pelvic dete...

Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging F...
https://doi.org/10.1002/jmri.27684
Journal of Magnetic Resonance Imaging : JMRI; Meng N, Fang T et. al.

May 15th, 2021 - Endometrial carcinoma (EC) risk stratification is generally based on histological assessment. It would be beneficial to perform risk stratification noninvasively by MRI. To investigate the application of amide proton transfer-weighted imaging (APT...

Endometrial Carcinoma as the Presenting Malignancy in a Teenager With a Pathogenic TP53...
https://doi.org/10.1097/PGP.0000000000000792
International Journal of Gynecological Pathology : Offici... Irshaid L, Clark M et. al.

May 14th, 2021 - Patients with germline TP53 mutations are characterized by the occurrence of multiple early-onset malignancies. The characteristic syndrome is Li-Fraumeni syndrome (OMIM # 151623), an autosomal dominant disorder typified by premenopausal breast ca...

The impact of race, comorbid conditions and obesity on survival endpoints in women with...
https://doi.org/10.1016/j.ygyno.2021.04.036
Gynecologic Oncology; Fucinari J, Elshaikh MA et. al.

May 14th, 2021 - To estimate overall survival, disease-specific survival, and progression-free survival among high grade endometrial carcinoma cases and to determine factors impacting survival for non-Hispanic white and non-Hispanic black women. We identified high...

Economic evaluation of different routes of surgery for the management of endometrial ca...
https://doi.org/10.1136/bmjopen-2020-045888
BMJ Open; Moss EL, Morgan G et. al.

May 14th, 2021 - The benefits of minimally invasive surgery (MIS) for endometrial carcinoma (EC) are well established although the financial impact of robotic-assisted hysterectomy (RH) compared with laparoscopic hysterectomy (LH) is disputed. Retrospective cohort...

see more →

Guidelines  23 results

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.
https://doi.org/10.1016/j.jacr.2020.09.001
Journal of the American College of Radiology : JACR; , Reinhold C et. al.

Nov 6th, 2020 - To date, there is little consensus on the role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial carcinoma, with practices differing widely across centers. However, when pretreatment assessment...

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
https://www.mrknewsroom.com/news-release/oncology/fda-approves-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-treatm

Sep 16th, 2019 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available ki...

Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma
https://www.nature.com/articles/s41379-019-0220-1
Yano,M.,et al

Feb 10th, 2019 - Endometrial endometrioid carcinoma is usually divided into three histological subgroups: grade 1 (G1), grade 2 (G2), and grade 3 (G3). Most cases of endometrial endometrioid carcinoma G1/2 have a favorable prognosis, although some can have unfavor...

The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmen...
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/The-Role-of-Transvaginal-Ultrasonography-in-Evaluating-the-Endometrium-of-Women-With-Postmenopausal
Committee on Gynecologic Practice

Apr 30th, 2018 - Cancer of the endometrium is the most common type of gynecologic cancer in the United States. Vaginal bleeding is the presenting sign in more than 90% of postmenopausal women with endometrial carcinoma.

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/16/2/170.full
Koh, W.

Jan 31st, 2018 - Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  3,605 results

Combined use of ICG and technetium does not improve sentinel lymph node detection in en...
https://doi.org/10.1016/j.ygyno.2021.05.002
Gynecologic Oncology; Cabrera S, Barahona-Orpinell M et. al.

May 16th, 2021 - There is scarce evidence available about the benefit of combining technetium (99mTc) and indocyanine green (ICG) for sentinel lymph node (SLN) biopsy in endometrial cancer. The aim of this study was to compare the overall and bilateral pelvic dete...

Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging F...
https://doi.org/10.1002/jmri.27684
Journal of Magnetic Resonance Imaging : JMRI; Meng N, Fang T et. al.

May 15th, 2021 - Endometrial carcinoma (EC) risk stratification is generally based on histological assessment. It would be beneficial to perform risk stratification noninvasively by MRI. To investigate the application of amide proton transfer-weighted imaging (APT...

Endometrial Carcinoma as the Presenting Malignancy in a Teenager With a Pathogenic TP53...
https://doi.org/10.1097/PGP.0000000000000792
International Journal of Gynecological Pathology : Offici... Irshaid L, Clark M et. al.

May 14th, 2021 - Patients with germline TP53 mutations are characterized by the occurrence of multiple early-onset malignancies. The characteristic syndrome is Li-Fraumeni syndrome (OMIM # 151623), an autosomal dominant disorder typified by premenopausal breast ca...

The impact of race, comorbid conditions and obesity on survival endpoints in women with...
https://doi.org/10.1016/j.ygyno.2021.04.036
Gynecologic Oncology; Fucinari J, Elshaikh MA et. al.

May 14th, 2021 - To estimate overall survival, disease-specific survival, and progression-free survival among high grade endometrial carcinoma cases and to determine factors impacting survival for non-Hispanic white and non-Hispanic black women. We identified high...

Economic evaluation of different routes of surgery for the management of endometrial ca...
https://doi.org/10.1136/bmjopen-2020-045888
BMJ Open; Moss EL, Morgan G et. al.

May 14th, 2021 - The benefits of minimally invasive surgery (MIS) for endometrial carcinoma (EC) are well established although the financial impact of robotic-assisted hysterectomy (RH) compared with laparoscopic hysterectomy (LH) is disputed. Retrospective cohort...

see more →

News  47 results

The role of hysteroscopy in diagnosing endometrial cancer
https://www.mdedge.com/obgyn/article/218597/gynecologic-cancer/role-hysteroscopy-diagnosing-endometrial-cancer/page/0/3?channel=217

Mar 6th, 2020 - Potential for intraperitoneal dissemination of endometrial cancer There is some concern about intraperitoneal dissemination of endometrial carcinoma at the time of hysteroscopy and effect on disease prognosis. Chang and colleagues conducted a larg.

Proteogenomics provides molecular insights into endometrial carcinoma
https://www.mdedge.com/hematology-oncology/article/217509/gynecologic-cancer/proteogenomics-provides-molecular-insights?channel=39313
Caleb Rans

Feb 19th, 2020 - Newly discovered insights into the underlying molecular and immune mechanisms of endometrial carcinoma may reveal novel therapeutic targets and improve immunotherapy selection for patients, according to a proteogenomic study. Further insights into.

FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma
https://www.mdedge.com/obgyn/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo-advanced?channel=27979
Lucas Franki

Sep 17th, 2019 - The Food and Drug Administration has granted accelerated approval to a pembrolizumab (Keytruda) plus lenvatinib (Lenvima) combination for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability high or.

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
https://www.mrknewsroom.com/news-release/oncology/fda-approves-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-treatm

Sep 16th, 2019 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available ki...

US, Canada, Australia Simultaneously Approve Endometrial Cancer Combo
https://www.medscape.com/viewarticle/918531

Sep 16th, 2019 - The US Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA), and Health Canada (HC) today simultaneously approved a new two-drug combination for the treatment of advanced endometrial carcinoma. The three agenci...

see more →